PregLem Company
PregLem is a Swiss biopharmaceutical company that focuses on developing and selling innovative drugs for women's reproductive medicine.
.jpg)
Total Funding:
$58,248,124
Headquarters:
Geneva
Funding Status:
M&A
Employee Number:
11-50
Last Funding Type:
Series B
Last Funding Date:
2007-12-04
Investors Number:
4
Founded Date:
2006
Industry:
Reproductive Health & Contraception